Jul 10 2008, 3:22 PM EST
News source: Business Wire
The Arizona BioIndustry Association (AZBio) has added three new
members to its Board of Directors, which was restructured earlier this
year to assist AZBio in more effectively operating as a unified
association representing the interests of all bioscience companies
throughout the state.
The three new Directors are Monique Heiser, Vice President and
General Manager of the Covance Laboratories facility under
construction in Chandler; Randal Schulhauser, Sr., Manager of
Technology & Business Development at Medtronic Microelectronic Center
in Tempe; and Raymond Woosley, President and CEO of Critical Path
Institute in Tucson.
"I'm pleased to welcome these three outstanding individuals to the
AZBio Board," said Michael Mobley, Associate Director of the Biodesign
Institute at Arizona State University and Chair of the AZBio Board of
Directors. "Arizona's bioscience companies are part of a global
industry, and it will be valuable to have the perspective of these
prominent organizations as we continue to develop a varied portfolio
of benefits for our members."
Robert Eaton, AZBio's President & CEO, said, "AZBio represents all
bioscience companies in the state, regardless of geography, size or
stage of development. I am excited that our Board of Directors will
now more fully represent the spectrum of organizations that make up
Arizona's bioscience community."
The Arizona BioIndustry Association is a not-for-profit trade
association that seeks to unify, empower and advance its member
organizations, who collectively form Arizona's bioscience community,
and to make Arizona a place where bioscience companies can grow and
succeed. AZBio is the state affiliate in Arizona for both the
Biotechnology Industry Organization (BIO), the preeminent trade
association for the biotechnology industry in the United States, and
AdvaMed, a national trade association whose members produce nearly 90
percent of the health care technology purchased annually in the United
States.
Covance, with headquarters in Princeton, New Jersey, is one of the
world's largest and most comprehensive drug development services
companies with annual revenues greater than $1.5 billion, global
operations in more than 20 countries, and more than 8,900 employees
worldwide. Information on Covance's products and services, recent
press releases, and SEC filings can be obtained through its website at
www.covance.com.
Medtronic, Inc., headquartered in Minneapolis, is the world's
leading medical technology company, alleviating pain, restoring health
and extending life for people with chronic disease. Each year, over 6
million patients benefit from Medtronic's technologies used to treat
conditions such as heart disease, spinal conditions, neurological
disorders, vascular disease and diabetes. Medtronic has almost 38,000
employees working in over 120 countries, generating annual revenues
exceeding $13.505B. (www.medtronic.com)
Critical Path Institute, headquartered in Tucson, Arizona, with
offices in Rockville, Maryland, was established in 2005 as a publicly
funded, nonprofit research and education institute to enable
collaborations between scientists from the FDA, industry and academia.
Critical Path Institute's mission is to help implement the FDA's
Critical Path Initiative by developing faster, safer and smarter
pathways to new medical products. Visit www.C-Path.org for more
information.
ADVERTISEMENT
INTERVIEW:
NEW PROGNOSTIC GENETIC TEST FOR ADOLESCENT SCOLIOSIS - Interview with Dr. Baron Lonner, director of Scoliosis and Spine Associates
...MORE
NewsArticles BlogsADVERTISEMENT
Subscribe to RSS
Email
Print
Share
More News
Listen
Save
Comment
View All